These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27106500)

  • 1. Assessment of advanced glycated end product accumulation in skin using auto fluorescence multispectral imaging.
    Larsson M; Favilla R; Strömberg T
    Comput Biol Med; 2017 Jun; 85():106-111. PubMed ID: 27106500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of the facial glycation imaging system for in situ human face skin glycation index measurement.
    Lee J; Jeong ET; Lim JM; Park SG
    J Cosmet Dermatol; 2021 Sep; 20(9):2963-2968. PubMed ID: 33522691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive measurement of advanced glycation end-products in the facial skin: New data for skin aging studies.
    Qu D; Venzon D; Murray M; Depauw M
    J Cosmet Sci; 2017; 68(3):195-204. PubMed ID: 29616620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of Advanced Glycation Endproducts and Subclinical Inflammation in Deep Tissues of Adult Patients With and Without Diabetes.
    Hu H; Jiang H; Zhu L; Wu X; Han C
    Can J Diabetes; 2018 Oct; 42(5):525-532.e4. PubMed ID: 29803627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin Autofluorescence Examination as a Diagnostic Tool for Mild Cognitive Impairment in Healthy People.
    Igase M; Ohara M; Igase K; Kato T; Okada Y; Ochi M; Tabara Y; Kohara K; Ohyagi Y
    J Alzheimers Dis; 2017; 55(4):1481-1487. PubMed ID: 27858716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive assessments of the advanced glycation end products in human skin using reflectance NIR spectroscopy.
    Shin ES; Sang Park Y; Nam SH
    Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():5506-5509. PubMed ID: 31947101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin autofluorescence, a non-invasive marker for AGE accumulation, is associated with the degree of atherosclerosis.
    den Dekker MA; Zwiers M; van den Heuvel ER; de Vos LC; Smit AJ; Zeebregts CJ; Oudkerk M; Vliegenthart R; Lefrandt JD; Mulder DJ
    PLoS One; 2013; 8(12):e83084. PubMed ID: 24376641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end-products (AGEs) accumulation in skin: relations with chronic kidney disease-mineral and bone disorder.
    França RA; Esteves ABA; Borges CM; Quadros KRDS; Falcão LCN; Caramori JCT; Oliveira RB
    J Bras Nefrol; 2017; 39(3):253-260. PubMed ID: 28902232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of skin autofluorescence as a marker of advanced glycation end product accumulation in type 1 diabetes.
    Samborski P; Naskręt D; Araszkiewicz A; Niedźwiecki P; Zozulińska-Ziółkiewicz D; Wierusz-Wysocka B
    Pol Arch Med Wewn; 2011 Mar; 121(3):67-72. PubMed ID: 21430607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of advanced glycation end products, evaluated by skin autofluorescence, with lifestyle habits in a general Japanese population.
    Isami F; West BJ; Nakajima S; Yamagishi SI
    J Int Med Res; 2018 Mar; 46(3):1043-1051. PubMed ID: 29322837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end-products (AGEs) and associations with cardio-metabolic, lifestyle, and dietary factors in a general population: the NQplus study.
    Botros N; Sluik D; van Waateringe RP; de Vries JHM; Geelen A; Feskens EJM
    Diabetes Metab Res Rev; 2017 Jul; 33(5):. PubMed ID: 28249105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel imaging platform for non-invasive screening of abnormal glucose tolerance.
    Jeong B; Jung CH; Lee YH; Shin IH; Kim H; Bae SJ; Lee DS; Kang ES; Kang U; Kim JJ; Park JY
    Diabetes Res Clin Pract; 2016 Jun; 116():83-5. PubMed ID: 27321320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced Glycation Endproducts as Biomarkers for Risk of Diabetes and Cardiovascular Diseases by Skin Autofluorescence: A Noninvasive Optical Screening.
    Paolillo FR; Mattos VS; Borghi-Silva A; Bagnato VS; de Castro Neto JC
    Photobiomodul Photomed Laser Surg; 2019 Mar; 37(3):168-174. PubMed ID: 31050947
    [No Abstract]   [Full Text] [Related]  

  • 14. Within- and Between-Body-Site Agreement of Skin Autofluorescence Measurements in People With and Without Diabetes-Related Foot Disease.
    Fernando ME; Crowther RG; Lazzarini PA; Sangla KS; Wearing S; Buttner P; Golledge J
    J Diabetes Sci Technol; 2019 Sep; 13(5):836-846. PubMed ID: 31204497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple non-invasive assessment of advanced glycation endproduct accumulation.
    Meerwaldt R; Graaff R; Oomen PHN; Links TP; Jager JJ; Alderson NL; Thorpe SR; Baynes JW; Gans ROB; Smit AJ
    Diabetologia; 2004 Jul; 47(7):1324-1330. PubMed ID: 15243705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing a Portable Autofluorescence Detection System and Its Application in Biological Samples.
    Zhou J; Li Y; Zhang J; Cai F
    Sensors (Basel); 2024 May; 24(11):. PubMed ID: 38894145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations.
    Mulder DJ; Water TV; Lutgers HL; Graaff R; Gans RO; Zijlstra F; Smit AJ
    Diabetes Technol Ther; 2006 Oct; 8(5):523-35. PubMed ID: 17037967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased accumulation of skin advanced glycation end products is associated with microvascular complications in type 1 diabetes.
    Araszkiewicz A; Naskret D; Niedzwiecki P; Samborski P; Wierusz-Wysocka B; Zozulinska-Ziolkiewicz D
    Diabetes Technol Ther; 2011 Aug; 13(8):837-42. PubMed ID: 21568748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reference values of skin autofluorescence as an estimation of tissue accumulation of advanced glycation end products in a general Slovak population.
    Simon Klenovics K; Kollárová R; Hodosy J; Celec P; Sebeková K
    Diabet Med; 2014 May; 31(5):581-5. PubMed ID: 24111899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polarization enhanced wide-field imaging for evaluating dermal changes caused by non-ablative fractional laser treatment.
    Feng X; Doherty S; Yaroslavsky I; Altshuler G; Yaroslavsky AN
    Lasers Surg Med; 2016 Feb; 48(2):150-6. PubMed ID: 26304187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.